SHS Private Equity

Due to the continuous growth of the different fund generations, SHS IV is going to invest predominantly in already established corporations within the MedTech and adjacent sectors.

SHS takes part in transactions with a total volume of up to € 100m within the MedTech/Life Sciences business. SHS IV provides between € 2m and € 20m as equity, but can engage in much larger transactions thanks to its distinctive network of co-investors.

Besides majorities, also minority investments are considered. Motives for an investment may have different origins. Our geographical focus is concentrated on the German-speaking countries as well as Scandinavia and the Benelux countries.

We are looking forward to hearing from you.